Search
                    Jacksonville, FL Paid Clinical Trials
A listing of 842  clinical trials  in Jacksonville, FL  actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
            577 - 588 of 842
        
                There are currently 842 clinical trials in Jacksonville, Florida looking for participants to engage in research studies. Trials are conducted at various facilities, including Mayo Clinic in Florida, Mayo Clinic - Jacksonville, Mayo Clinic and Mayo Clinic Florida. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you. 
            
                                        Featured Trial
                
                Healthy Participants Needed (Colonoscopy + Cancer Screening)
            
        Recruiting
            
        Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
    
    
                            Conditions: 
                                    
        
            
                        Healthy
                    
                                    
                        Healthy Volunteers
                    
                                    
                        Healthy Subjects
                    
                                    
                        Healthy Volunteer
                    
                                    
                        Healthy Participants
                    
                                    Featured Offer
                
                Lose Weight with GLP-1 Medications
            
        Recruiting
            
        Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®. 
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
    GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
                            Conditions: 
                                    
        
            
                        Overweight
                    
                                    
                        Overweight and Obesity
                    
                                    
                        Obesity
                    
                                    
                        Weight Loss
                    
                                    
                        Morbid Obesity
                    
                                    Featured Trial
                
                Stroke Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Stroke
    
    
                            Conditions: 
                                    
        
            
                        Stroke
                    
                                    Featured Trial
                
                Chronic Kidney Disease (CKD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Chronic Kidney Disease (CKD)
    
    
                            Conditions: 
                                    
        
            
                        Chronic Kidney Disease (CKD)
                    
                                    Featured Trial
                
                Ischemic heart disease (IHD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Ischemic heart disease (IHD)
    
    
                            Conditions: 
                                    
        
            
                        Ischemic heart disease (IHD)
                    
                                    Featured Trial
                
                Cardiovascular Disease Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Cardiovascular Disease
    
    
                            Conditions: 
                                    
        
            
                        Cardiovascular Disease
                    
                                    
                
                                    Post Approval Study (PAS) of the OPTIMIZER Smart and CCM Therapy
                                
            
            
        Recruiting
                            
            
                The OPTIMIZER Smart Post-Approval Study is a prospective, multi-center, non-randomized, single arm open label study of 620 subjects receiving an OPTIMIZER implant as standard of care. Patients to be included will have NYHA functional class III symptoms and a left ventricular ejection fraction of 25-45%             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                05/05/2025
            
            Locations: Florida Memorial Hospital, Jacksonville, Florida         
        
        
            Conditions: Heart Failure
        
            
        
    
                
                                    Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALS
                                
            
            
        Recruiting
                            
            
                A Phase 2b/3 multicenter, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy, safety and tolerability of MN-166 given to ALS participants for 12 months followed by a 6-month open-label extension phase.             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 80 years
            Trial Updated:
                05/05/2025
            
            Locations: Mayo Clinic, Jacksonville, Florida         
        
        
            Conditions: Amyotrophic Lateral Sclerosis
        
            
        
    
                
                                    Up-2 Study: Cognitively Engaging Walking Exercise and Neuromodulation to Enhance Brain Function in Older Adults
                                
            
            
        Recruiting
                            
            
                Declines in cognitive function and walking function are highly intertwined in older adults. A therapeutic approach that combines complex (cognitively engaging) aerobic walking exercise with non-invasive electrical brain stimulation may be effective at restoring lost function. This study tests whether electrical stimulation of prefrontal brain regions is more beneficial than sham stimulation.             
        
        
    Gender:
                ALL
            Ages:
                65 years and above
            Trial Updated:
                05/05/2025
            
            Locations: Brooks Rehabilitation, Jacksonville, Florida         
        
        
            Conditions: Cognitive Dysfunction, Mobility Limitation, Frail Elderly
        
            
        
    
                
                                    TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
                                
            
            
        Recruiting
                            
            
                This study is a non-interventional, multicenter, multicohort evaluation of participants with cancer who will undergo longitudinal plasma ctDNA biomarker profiling at specific time points in addition to standard of care therapy.             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 99 years
            Trial Updated:
                05/05/2025
            
            Locations: Cancer Specialists of North Florida, Jacksonville, Florida         
        
        
            Conditions: Cancer
        
            
        
    
                
                                    Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
                                
            
            
        Recruiting
                            
            
                This is a Phase 1, open-label, multicenter, study of the safety, tolerability, PK, PD, and anti-tumor activity of MRTX1719 patients with advanced, unresectable or metastatic solid tumor malignancy with homozygous deletion of the MTAP gene.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                05/02/2025
            
            Locations: Mayo Clinic, Jacksonville, Florida         
        
        
            Conditions: Mesothelioma, Non Small Cell Lung Cancer, Malignant Peripheral Nerve Sheath Tumors, Solid Tumor, Pancreatic Adenocarcinoma, Advanced Solid Tumor
        
            
        
    
                
                                    Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury
                                
            
            
        Recruiting
                            
            
                This pilot study will determine the feasibility of implementing a combinatory rehabilitation strategy involving testosterone replacement therapy (TRT) with locomotor training (LT; walking on a treadmill with assistance and overground walking) in men with testosterone deficiency and walking dysfunction after incomplete or complete spinal cord injury. The investigators hypothesize that LT+TRT treatment will improve muscle size and bone mineral density in men with low T and ambulatory dysfunction a...  Read More             
        
        
    Gender:
                MALE
            Ages:
                18 years and above
            Trial Updated:
                05/01/2025
            
            Locations: Brooks Rehabilitation, Jacksonville, Florida         
        
        
            Conditions: Spinal Cord Injury, Spinal Cord Injuries, Trauma, Nervous System, Wounds and Injury, Central Nervous System Diseases, Spinal Cord Diseases, Gonadal Disorders, Endocrine System Diseases, Hypogonadism, Genital Diseases, Male, Spinal Cord Trauma, Injuries, Spinal Cord, Walking, Difficulty, Gait Disorders, Neurologic, Locomotion Disorder, Neurologic, Wounds and Injuries, Nervous System Diseases, Testosterone Deficiency, Androgen Deficiency, Hormone Deficiency
        
            
        
    
                
                                    Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors
                                
            
            
        Recruiting
                            
            
                This Phase III trial will examine the efficacy of computerized cognitive training methods on perceived cognitive impairment in breast cancer survivors.             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 100 years
            Trial Updated:
                05/01/2025
            
            Locations: Mayo Clinic in Florida, Jacksonville, Florida         
        
        
            Conditions: Breast Cancer, Cognitive Impairments
        
            
        
    
                
                                    Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
                                
            
            
        Recruiting
                            
            
                This is a Phase 1/2 study to evaluate the safety and tolerability of 18F-OP-801 in subjects with ALS, AD, MS, PD and age-matched HVs. 18F-OP-801 is intended as a biomarker for PET imaging of activated microglia and macrophages in regions of neuroinflammation.             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 80 years
            Trial Updated:
                04/30/2025
            
            Locations: Mayo Clinic Jacksonville, Jacksonville, Florida         
        
        
            Conditions: Amyotrophic Lateral Sclerosis (ALS), Parkinson Disease (PD), Alzheimer Disease (AD), Multiple Sclerosis (MS)
        
            
        
    
                
                                    MitraClip REPAIR MR Study
                                
            
            
        Recruiting
                            
            
                The objective of this randomized controlled trial (RCT) is to compare the clinical outcome of MitraClip™ device versus surgical repair in patients with severe primary MR who are at moderate surgical risk and whose mitral valve has been determined to be suitable for correction by MV repair surgery by the cardiac surgeon on the local site heart team.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                04/29/2025
            
            Locations: Baptist Medical Center, Jacksonville, Florida         
        
        
            Conditions: Mitral Valve Regurgitation
        
            
        
    
                
                                    Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
                                
            
            
        Recruiting
                            
            
                The purpose of this trial is to generate clinical evidence related to key performance outcomes of Endurant II/IIs Stent Graft Systems verses Gore Excluder / Excluder Conformable AAA Endoprosthesis in subjects with Abdominal Aortic Aneurysms. Subjects are randomized and imaging collected at all follow-up time points to assess the primary endpoint.             
        
        
    Gender:
                ALL
            Ages:
                20 years and above
            Trial Updated:
                04/29/2025
            
            Locations: Mayo Clinic Jacksonville, Jacksonville, Florida         
        
        
            Conditions: Abdominal Aortic Aneurysm, Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder), Abdominal Aortic Aneurysm >= 5.0 Centimeters in Female (Disorder)
        
            
        
    
                
                                    Allogeneic BM-MSC's in Patients With Lumbar Facet Arthropathy
                                
            
            
        Recruiting
                            
            
                The purpose of this research study is to evaluate the safety and effect of bone marrow-derived stem cells for the treatment of low back pain.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                04/29/2025
            
            Locations: Mayo Clinic in Florida, Jacksonville, Florida         
        
        
            Conditions: Facet-Mediated Low Back Pain
        
            
        
    
                
                                    Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
                                
            
            
        Recruiting
                            
            
                The aim for this study is to assess the diagnostic performance of 64Cu-SAR-bisPSMA PET to detect regional nodal metastases.             
        
        
    Gender:
                MALE
            Ages:
                18 years and above
            Trial Updated:
                04/29/2025
            
            Locations: Mayo Clinic- Jacksonville, Jacksonville, Florida         
        
        
            Conditions: Prostate Cancer, Prostatic Neoplasms
        
            
        
    577 - 588 of 842
            